Breast cancer is the second most common cancer among women globally, after skin cancer. Obesity contributes to this risk in various ways. According to Dr. Sue Decotiis, a New York-based weight-loss specialist who was not involved in the study, obesity leads to systemic inflammation that disrupts immune function, cellular regulation, and even the gut microbiome. She noted that even modest reductions in fat mass can lead to measurable anti-inflammatory effects, which may be beneficial in preventing or slowing cancer progression.
